Premier Fund Managers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $650K | Sell |
3,049
-1,125
| -27% | -$250K | 0.05% | 116 |
|
|
2025
Q4 | $959K | Sell |
4,174
-500
| -11% | -$114K | 0.06% | 99 |
|
|
2025
Q3 | $1.04M | Sell |
4,674
-700
| -13% | -$143K | 0.04% | 100 |
|
|
2025
Q2 | $980K | Buy |
5,374
+300
| +6% | +$55.8K | 0.04% | 106 |
|
|
2025
Q1 | $1.04M | Sell |
5,074
-2,573
| -34% | -$500K | 0.04% | 108 |
|
|
2024
Q4 | $1.35M | Buy |
7,647
+2,400
| +46% | +$441K | 0.05% | 117 |
|
|
2024
Q3 | $1.02M | Hold |
5,247
| – | – | 0.04% | 123 |
|
|
2024
Q2 | $887K | Sell |
5,247
-46,782
| -90% | -$7.75M | 0.04% | 124 |
|
|
2024
Q1 | $9.38M | Sell |
52,029
-15,587
| -23% | -$2.69M | 0.37% | 55 |
|
|
2023
Q4 | $10.5M | Sell |
67,616
-5,113
| -7% | -$745K | 0.45% | 53 |
|
|
2023
Q3 | $11.1M | Sell |
72,729
-3,991
| -5% | -$586K | 0.52% | 48 |
|
|
2023
Q2 | $10.2M | Buy |
76,720
+1,992
| +3% | +$292K | 0.41% | 55 |
|
|
2023
Q1 | $11.8M | Sell |
74,728
-7,254
| -9% | -$1.11M | 0.47% | 47 |
|
|
2022
Q4 | $13.3M | Buy |
81,982
+80,151
| +4,377% | +$12.3M | 0.52% | 45 |
|
|
2022
Q3 | $261K | Sell |
1,831
-86,045
| -98% | -$12.3M | 0.02% | 158 |
|
|
2022
Q2 | $13.5M | Buy |
87,876
+2,466
| +3% | +$377K | 0.6% | 49 |
|
|
2022
Q1 | $14M | Sell |
85,410
-10,032
| -11% | -$1.46M | 0.49% | 67 |
|
|
2021
Q4 | $13M | Buy |
95,442
+1,961
| +2% | +$232K | 0.42% | 68 |
|
|
2021
Q3 | $10.2M | Buy |
93,481
+10,516
| +13% | +$1.2M | 0.33% | 80 |
|
|
2021
Q2 | $9.32M | Buy |
82,965
+3,526
| +4% | +$397K | 0.32% | 81 |
|
|
2021
Q1 | $8.48M | Buy |
79,439
+2,199
| +3% | +$235K | 0.33% | 81 |
|
|
2020
Q4 | $8.13M | Buy |
77,240
+6,255
| +9% | +$601K | 0.35% | 70 |
|
|
2020
Q3 | $6.17M | Sell |
70,985
-1,592
| -2% | -$150K | 0.35% | 81 |
|
|
2020
Q2 | $7M | Sell |
72,577
-2,927
| -4% | -$258K | 0.44% | 67 |
|
|
2020
Q1 | $5.68M | Sell |
75,504
-58
| -0.1% | -$4.94K | 3.68% | 6 |
|
|
2019
Q4 | $6.69M | Sell |
75,562
-16,520
| -18% | -$1.37M | 3.38% | 4 |
|
|
2019
Q3 | $6.89M | Buy |
92,082
+18,320
| +25% | +$1.26M | 3.34% | 3 |
|
|
2019
Q2 | $5.16M | Buy |
73,762
+2,576
| +4% | +$202K | 2.36% | 23 |
|
|
2019
Q1 | $5.54M | Buy |
71,186
+18,385
| +35% | +$1.5M | 2.53% | 19 |
|
|
2018
Q4 | $4.81M | Buy |
52,801
+6,159
| +13% | +$542K | 2.8% | 9 |
|
|
2018
Q3 | $4.39M | Buy |
46,642
+6,386
| +16% | +$606K | 2.51% | 23 |
|
|
2018
Q2 | $3.72M | Buy |
+40,256
| New | +$3.93M | 2.23% | 21 |
|
Other funds holding ABBV
VCM
VPM
Premier Fund Managers's ABBV Position: Q1 2026 in Review
Premier Fund Managers reduced its AbbVie (ABBV) stake by 27% in Q1 2026, selling an estimated $250K and leaving 3,049 shares worth $650K. The position accounts for 0.05% of the portfolio, ranked #116.
Premier Fund Managers first reported a position in ABBV in Q2 2018 and has held it in 32 quarters since. The position peaked at $14M in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Premier Fund Managers held 3,049 shares of AbbVie worth $650K as of Q1 2026.
- Premier Fund Managers sold 1,125 AbbVie shares in Q1 2026, an estimated $250K.
- AbbVie made up 0.05% of Premier Fund Managers's portfolio in Q1 2026, its #116 holding.
- Premier Fund Managers first reported a position in AbbVie in Q2 2018 and has held it in 32 quarters since.
- Premier Fund Managers's AbbVie position peaked at $14M in Q1 2022.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Premier Fund Managers's 13F filing for Q1 2026, filed 14 May 2026.